|
|
Volumn 303, Issue 17, 2010, Pages 1681-1683
|
|
Aggressive lipid, hypertension targeting yields no benefit for some with diabetes
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FENOFIBRATE;
FIBRIC ACID DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID;
PLACEBO;
SIMVASTATIN;
THIAZIDE DIURETIC AGENT;
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
BLOOD PRESSURE REGULATION;
CARDIOVASCULAR RISK;
CLINICAL DECISION MAKING;
CLINICAL TRIAL;
DIABETES MELLITUS;
HUMAN;
HYPERTENSION;
LIPID BLOOD LEVEL;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
SHORT SURVEY;
TREATMENT OUTCOME;
CARDIOVASCULAR DISEASE;
HYPERLIPIDEMIA;
NOTE;
ANTIHYPERTENSIVE AGENTS;
ANTILIPEMIC AGENTS;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS AS TOPIC;
DIABETES COMPLICATIONS;
HUMANS;
HYPERLIPIDEMIAS;
HYPERTENSION;
|
|
EID: 77951885587
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2010.492 Document Type: Short Survey |
|
Times cited : (7)
|
|
References (0)
|
